Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design
Clinical trial NCT06369727 · COMPLETED
Trial details
- NCT number
- NCT06369727
- Sponsor
- Moberg Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-15
- Primary completion
- 2018-02-15
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.